ARTICLE | Company News
Tacere, Pfizer deal
February 8, 2010 8:00 AM UTC
Pfizer exercised its option under a 2008 deal to license exclusive, worldwide rights, excluding Asia, to develop and commercialize a family of HCV compounds from Tacere. The compounds include TT-034 ...